Patent · US Expired

Pharmaceutical compounds

US5589501A · kind A · utility

42Cited by
0References
7Claims
0Family size

Assignees

Inventors

Key dates

Filing dateNov 22, 1994
Grant dateDec 31, 1996
Priority date
Expiry dateNov 22, 2014

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07C229/36
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

A pharmaceutical compound of the formula ##STR1## in which m is 0, 1 or 2, n and q are each 0 or 1 to 5, and p is 0 or 1, X is --CO.sub.2 H or tetrazolyl, PA1 Y is --CH.dbd.CH--, and PA1 Z is PA2 (i) phenyl, naphthyl or thienyl, said phenyl, naphthyl and thienyl being optionally substituted, PA2 (ii) --CHR.sup.1 R.sup.2 where R.sup.1 and R.sup.2 are each phenyl, naphthyl or thienyl, said phenyl, naphthyl and thienyl being optionally substituted, PA2 (iii) .dbd.CR.sup.1 R.sup.2 where R.sup.1 and R.sup.2 are each phenyl, naphthyl or thienyl, said phenyl, naphthyl and thienyl being optionally substituted, or PA2 (iv) ##STR2## where r is 0 or 1 to 3 and the phenyl rings are optionally substituted; provided that when Z is phenyl and m is 1, p is 1; and salts and esters thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.